Wall Street analysts expect that U.S. Physical Therapy, Inc. (NYSE:USPH) will announce earnings of $0.71 per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for U.S. Physical Therapy’s earnings. The highest EPS estimate is $0.72 and the lowest is $0.71. U.S. Physical Therapy posted earnings of $0.64 per share in the same quarter last year, which suggests a positive year over year growth rate of 10.9%. The business is scheduled to announce its next earnings report before the market opens on Thursday, November 7th.
According to Zacks, analysts expect that U.S. Physical Therapy will report full-year earnings of $2.94 per share for the current fiscal year, with EPS estimates ranging from $2.93 to $2.95. For the next fiscal year, analysts anticipate that the firm will report earnings of $3.21 per share, with EPS estimates ranging from $3.13 to $3.26. Zacks’ earnings per share averages are a mean average based on a survey of research analysts that follow U.S. Physical Therapy.
U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.81 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.81. U.S. Physical Therapy had a return on equity of 19.19% and a net margin of 6.22%. The business had revenue of $126.40 million during the quarter, compared to analyst estimates of $124.86 million. During the same period in the prior year, the company posted $0.73 EPS. The business’s revenue for the quarter was up 9.8% compared to the same quarter last year.
A number of equities analysts recently issued reports on the company. Zacks Investment Research reissued a “buy” rating and issued a $145.00 price objective on shares of U.S. Physical Therapy in a report on Saturday, October 5th. ValuEngine lowered U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. U.S. Physical Therapy has an average rating of “Hold” and a consensus price target of $119.54.
In other news, CEO Christopher J. Reading sold 7,000 shares of the firm’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $135.13, for a total transaction of $945,910.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Lawrance W. Mcafee sold 2,500 shares of the firm’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $131.50, for a total value of $328,750.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 22,803 shares of company stock valued at $3,067,830. 2.50% of the stock is currently owned by corporate insiders.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Geode Capital Management LLC lifted its stake in U.S. Physical Therapy by 11.9% during the fourth quarter. Geode Capital Management LLC now owns 146,667 shares of the company’s stock worth $15,011,000 after purchasing an additional 15,556 shares during the period. Great West Life Assurance Co. Can lifted its holdings in shares of U.S. Physical Therapy by 7.6% in the 1st quarter. Great West Life Assurance Co. Can now owns 17,517 shares of the company’s stock worth $1,838,000 after acquiring an additional 1,242 shares during the last quarter. Sawtooth Solutions LLC bought a new stake in shares of U.S. Physical Therapy in the 1st quarter worth approximately $297,000. Ontario Teachers Pension Plan Board bought a new stake in shares of U.S. Physical Therapy in the 1st quarter worth approximately $703,000. Finally, Neuberger Berman Group LLC lifted its holdings in shares of U.S. Physical Therapy by 4.6% in the 1st quarter. Neuberger Berman Group LLC now owns 902,762 shares of the company’s stock worth $94,817,000 after acquiring an additional 39,329 shares during the last quarter.
USPH stock traded up $2.33 on Friday, reaching $131.90. The company’s stock had a trading volume of 529 shares, compared to its average volume of 83,426. U.S. Physical Therapy has a 52 week low of $98.69 and a 52 week high of $138.58. The company has a market capitalization of $1.64 billion, a P/E ratio of 49.67, a price-to-earnings-growth ratio of 3.57 and a beta of 1.12. The firm has a fifty day moving average of $132.03 and a two-hundred day moving average of $122.17. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.88 and a quick ratio of 1.88.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
See Also: What is a growth and income fund?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.